MONDAY, Jan. 27, 2025 -- Heart disease continues to be a leading cause of death, according to a report from the American Heart Association published online Jan. 27 in

2025年1月27日，星期一——根据美国心脏协会1月27日在线发布的一份报告，心脏病仍然是导致死亡的主要原因

Circulation

流通

.

.

Seth S. Martin, M.D., from the Johns Hopkins University School of Medicine in Baltimore, and colleagues present the latest data on clinical heart and circulatory disease conditions and associated outcomes.

巴尔的摩约翰霍普金斯大学医学院的SethS.Martin博士及其同事提供了有关临床心脏和循环系统疾病状况及相关结果的最新数据。

According to the 2025 statistical update, the odds of cardiovascular disease were lower with every increasing one-standard deviation increment of the AHA Life's Essential 8 score (odds ratio, 0.64). Cardiovascular health score, as measured by the AHA Life's Essential 8, and components predicted major adverse cardiovascular events within the U.K.

根据2025年的最新统计数据，AHA Life Essential 8得分每增加一个标准差，心血管疾病的几率就会降低（优势比为0.64）。由AHA Life Essential 8测量的心血管健康评分和成分预测了英国境内的主要不良心血管事件。

Biobank. There was a consistent decline in adult and youth cigarette use during the past two decades, but disparities persist. From 2011 to 2021, there was a decrease in the percentage of high school students who were physically active for ≥60 minutes on all seven days of the week (from 28.7 to 23.9 percent).

生物库。在过去的二十年中，成人和青少年的吸烟量持续下降，但差距仍然存在。从2011年到2021年，在一周的所有七天中，体育锻炼时间≥60分钟的高中生比例有所下降（从28.7%降至23.9%）。

Most of the American population does not consume a healthy dietary pattern. The prevalence of obesity was 41.8 percent for men and women from 2017 to 2020. Prevalence of high blood pressure increased with age, reaching 76.5 percent among those aged 65 years and older..

大多数美国人口没有健康的饮食模式。2017年至2020年，男性和女性的肥胖患病率为41.8%。高血压患病率随着年龄的增长而增加，在65岁及以上的人群中达到76.5%。。

'The disparities in risk and outcomes call for tailored interventions among high-risk populations,' Dhruv S. Kazi, M.D., from Harvard Medical School in Boston and author of an accompanying editorial, said in a statement. 'Simply discovering breakthrough therapies isn't going to be enough -- we have to ensure that these therapies are accessible and affordable to people who need them most.'.

波士顿哈佛医学院医学博士、随附社论作者Dhruv S.Kazi在一份声明中说，风险和结果的差异要求对高危人群进行量身定制的干预仅仅发现突破性疗法是不够的——我们必须确保这些疗法能够为最需要它们的人提供并且负担得起。”。

Several authors disclosed ties to the pharmaceutical industry.

几位作者透露了与制药行业的关系。

Abstract/Full Text (subscription or payment may be required)

摘要/全文（可能需要订阅或付款）

Editorial (subscription or payment may be required)

编辑（可能需要订阅或付款）

Whatever your topic of interest,

无论你感兴趣的话题是什么，

subscribe to our newsletters

订阅我们的新闻稿

to get the best of Drugs.com in your inbox.

在收件箱中获取Drugs.com的最佳信息。